{
    "Orphapacket": {
        "ORPHApacketId": "456369",
        "creationDate": "2023-12-06 11:51:54",
        "version": "1.3.29 / 4.1.7 [2023-08-02] (orientdb version)",
        "copyright": "Orphanet (c) 2023",
        "ORPHAcode": "456369",
        "Label": "Polyglucosan body myopathy type 2",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_456369",
        "DisorderType": {
            "value": "Disease",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377788"
        },
        "ExternalReferences": [
            {
                "Source": "OMIM",
                "Reference": "616199",
                "DisorderMappingRelation": "E (Exact mapping: the two concepts are equivalent)"
            }
        ],
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A rare glycogen storage disease characterized by slowly progressive myopathy with storage of polyglucosan in muscle fibers. Age of onset ranges from childhood to late adulthood. Patients present proximal or proximodistal weakness predominantly of limb-girdle muscles. Variable features include exercise intolerance or myalgia. Serum creatine kinase is normal or mildly elevated. There is usually no overt cardiac involvement."
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "GYG1",
                    "Name": "glycogenin 1",
                    "ExternalReferences": [],
                    "DisorderGeneAssociationType": "Disease-causing germline mutation(s) (loss of function) in"
                }
            }
        ],
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "79201",
                        "Label": "Glycogen storage disease"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "206959",
                        "Label": "Muscular glycogenosis"
                    }
                ]
            },
            {
                "Parent": [
                    {
                        "ORPHAcode": "68385",
                        "Label": "Neurometabolic disease"
                    }
                ]
            }
        ],
        "Prevalences": [
            {
                "Prevalence": {
                    "Source": "25272951[PMID]_26203156[PMID]_26255073[PMID]_26652229[PMID]",
                    "PrevalenceType": "Cases/families",
                    "PrevalenceQualification": "Case",
                    "PrevalenceClass": "no data",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            },
            {
                "Prevalence": {
                    "Source": "ORPHANET_25272951[PMID]_26203156[PMID]_26255073[PMID]_26652229[PMID]",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Class only",
                    "PrevalenceClass": "<1 / 1 000 000",
                    "ValMoy": "no data",
                    "PrevalenceGeographic": "Worldwide"
                }
            }
        ],
        "AverageAgeOfOnsets": [
            {
                "AverageAgeOfOnset": {
                    "value": "Adolescent"
                }
            },
            {
                "AverageAgeOfOnset": {
                    "value": "Adult"
                }
            },
            {
                "AverageAgeOfOnset": {
                    "value": "Childhood"
                }
            },
            {
                "AverageAgeOfOnset": {
                    "value": "Elderly"
                }
            }
        ],
        "TypeOfInheritances": {
            "TypeOfInheritance": [
                {
                    "value": "Autosomal recessive"
                }
            ]
        }
    }
}